Content about Immunosuppressive agents

August 8, 2012

Teva, Active Biotech plan third MS drug trial

Drug makers Teva Pharmaceutical Industries and Active Biotech will start a third late-stage clinical trial of an experimental drug for treating multiple sclerosis, the companies said Wednesday.

March 15, 2012

Late-stage trial of MS drug shows positive results

A drug under investigation by Teva Pharmaceutical Industries and Active Biotech reduced symptoms and progression of disease in patients with multiple sclerosis, according to results of a late-stage clinical trial.

April 12, 2011

Teva, Active Biotech: Laquinimod reduces relapses, disease progression in MS patients

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

September 30, 2010

Teva unveils mid-stage clinical trial results for MS drug

Teva Pharmaceutical Industries and Active Biotech announced promising results from a mid-stage trial of laquinimod,...

June 13, 2010

FDA advisory committee gives nod to investigational MS drug

An advisory committee of the Food and Drug Administration unanimously recommended approval for an investigational...

January 20, 2010

Clinical trial finds Novartis drug reduces progression of MS

An investigational drug for treating multiple sclerosis reduced progression of disability by more than 30%,...